Medtech grants in Germany
Explore Medtech grants for companies in Germany. This list brings together funding for medical devices, diagnostics, digital health and clinical validation from German innovation agencies, research funders and foundations, EU and international programs open to applicants in Germany, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Medtech in Germany come first.
Showing 217-240 of 573 grants
Strategic Research Agreement — Round 1
Breakthrough T1D · United States
Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds proof-of-concept work on a genuinely new tool, assay, platform or instrument for characterising cancer cells or handling biospecimens.
Lupus Insight Prize
LRA · United States
Provides prize recognizing a specific significant recent lupus research discovery through the Lupus Insight Prize.
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
NIH · United States
Funds a company and an academic group working as one team to turn an imaging, spectroscopy or data-science advance into something usable in the clinic.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21)
NIH · United States
Funds smaller, higher-risk work on how GLP-1 and related drugs change cancer risk. No clinical trial in this version.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
Personal Health Informatics for Delivering Actionable Insights to Individuals
NIH · United States
Funds informatics tools that take a person's own health data and hand back a risk assessment they can understand and do something about.
Parkinson's Foundation Melvin Yahr Clinical Research Award
Parkinson's Foundation · United States
Supports early-career clinicians advancing Parkinson's disease care and research collaborations across emerging regions.
Translational Neural Devices
NIH · United States
Funds a therapeutic or diagnostic device for the nervous system through prototyping, safety testing, regulatory clearance and a first small clinical study.
Parkinson's Foundation Postdoctoral Fellowship — Basic Scientists
Parkinson's Foundation · United States
Supports early Parkinson's disease scientists building translational impact by funding postdoctoral research roles.
Parkinson's Foundation Postdoctoral Fellowship — Clinical Neurologists
Parkinson's Foundation · United States
Supports early-career neurologists launching Parkinson's disease research careers through postdoctoral fellowship funding.
CRI Irvington Postdoctoral Fellowship
CRI · United States
Funds three years of stipend support for postdocs training in immunology and cancer research.
Parkinson's Foundation Impact Awards
Parkinson's Foundation · United States
Funds independent Parkinson's disease investigators pursuing bold, high-risk projects with translational clinical relevance.
High Priority HIV and Substance Use Research (R01)
NIH · United States
Funds research where HIV and drug use intersect. Preliminary data are compulsory, and the work must sit on NIH's published HIV priorities.
Opportunities for Collaborative Research at the NIH Clinical Center
NIH · United States
Funds a translational research project run jointly with NIH's own intramural investigators at the Clinical Center, up to $500,000.
Integrating Biospecimen Science Approaches into Clinical Assay Development
NIH · United States
Funds research into how preanalytical handling of biopsies and other biospecimens distorts biomarker results used in clinical assays.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.